Pharmacotherapeutic considerations for the management of cardiovascular diseases among hospitalized COVID-19 patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacotherapeutic considerations for the management of cardiovascular diseases among hospitalized COVID-19 patients

Published:2020-07-27 Issue:8 Volume:18 Page:475-485
ISSN:1477-9072
Container-title:Expert Review of Cardiovascular Therapy
language:en
Short-container-title:Expert Review of Cardiovascular Therapy

Author:

Kow Chia Siang¹,Thiruchelvam Kaeshaelya²,Hasan Syed Shahzad²³^ORCID

Affiliation:

1. School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia

2. School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia

3. Department of Pharmacy, University of Huddersfield, Huddersfield, UK

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14779072.2020.1797492

Reference113 articles.

1. An interactive web-based dashboard to track COVID-19 in real time

2. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

3. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

4. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Statin and Clinical Outcomes in COVID-19 Patients: A Protocol for Systematic Review and Meta-analysis of Randomized Controlled Trials;Journal of Acute Care;2023-08-23

2. The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis;American Journal of Cardiovascular Drugs;2021-08-03

3. Epidemiology, prognosis and management of potassium disorders in Covid‐19;Reviews in Medical Virology;2021-06-02

4. Benefit versus toxicity risk of digoxin in patients with COVID-19;European Journal of Hospital Pharmacy;2021-06-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3